Capcom Delivers Early Verdicts on Street Fighter 6 and Exoprimal Sales

ign.com:

Capcom has issued verdicts on the initial sales performance of the recently-released Street Fighter 6 and Exoprimal.

Street Fighter 6 sold two million copies in just over a month which, in a note to investors, Capcom said was “generally progressing in line with our expectations”, adding it hoped positive word of mouth would fuel follow-up success.

“Compared to the internal plan for the title, sales are generally progressing in line with our expectations,” Capcom said. “We believe that its positive critical reception will work as a tailwind in expanding future sales of the game as a catalogue title.”

Capcom said it's aiming for Street Fighter 6 to outsell Street Fighter 5, which means selling over 10 million over the course of its lifetime.

“While we do not communicate specific figures for internal budgets, we look to outperform the title’s predecessor, Street Fighter 5, and are aiming for more than 10 million units over the life of the title,” Capcom said. Capcom declined to disclose Street Fighter 6 development costs.

Street Fighter 6 has just released its first DLC character, Rashid, and subsequent DLC character releases (including the hugely popular Akuma) should give sales a shot in the arm. Street Fighter 6’s top-billing at tournaments, such as the high-profile Evo event, should boost sales further.

Things sound less clear cut for Exoprimal, Capcom’s sci-fi dinosaur game. It launched straight onto Game Pass, which may have had a cannibalising effect on PC and Xbox version sales. Capcom admitted to “challenges”, given Exoprimal is a new IP, but pointed to the fact it had more than one million players as a “positive".

“Given that this game is an all-new IP, the situation is not without its challenges; however, we view the